Concepedia

Rasmus Jørgensen

RJ

Statistics

Publications

22

Citations

1K

H-Index

19

Active since

2004

Affiliations

Novo Nordisk (Denmark)(Current)

University of Copenhagen

Zealand Pharma (Denmark)

University of Washington

Dorn Research Institute

Rasmus Jørgensen is an author at Novo Nordisk (Denmark) specializing in life sciences, signal transduction, and cell signaling.

ORCID

Publications per year

2004–2021

22

Publications

22

Oxyntomodulin Differentially Affects Glucagon-Like Peptide-1 Receptor β-Arrestin Recruitment and Signaling through Gα

Rasmus Jørgensen, Valentina Kubale, Milka Vrecl et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 131 citations

, , +17

Metal Ion Site Engineering Indicates a Global Toggle Switch Model for Seven-transmembrane Receptor Activation

Christian Elling, Thomas M. Frimurer, Lars‐Ole Gerlach et al. · Journal of Biological Chemistry · 2006 · 92 citations · Full text

, , +16

Development of a BRET2 Screening Assay Using β-Arrestin 2 Mutants

Milka Vrecl, Rasmus Jørgensen, A. Pogačnik et al. · SLAS DISCOVERY · 2004 · 87 citations · Full text

, , +17

Characterization of Glucagon-Like Peptide-1 Receptor β-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype

Rasmus Jørgensen, Lene Martini, Thue W. Schwartz et al. · Molecular Endocrinology · 2004 · 76 citations · Full text

, , +17

Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain

Hanne Poulsen, Rasmus Jørgensen, Anders Heding et al. · RNA · 2006 · 66 citations · Full text

, , +16

1–5 of 22